在小儿冠状动脉CT血管学中,心率控制使用烯
Yosef A Cohen1,2, Luca Bremner3, Mrinali Shetty4
1Seymour, Paul and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, 622 West 168th Street PH 10-203, New York, NY 10032, USA.
European heart journal. Imaging methods and practice
|February 27, 2026
概括
在接受冠状动脉CT血管造影 (CCTA) 的儿童中,烯有效降低了心率 (HR),使诊断图像质量. 这项研究发现,儿科患者的HR显著下降,没有报告的不良影响.
科学领域:
- 心血管成像 - 心血管成像
- 儿科放射学 儿科放射学
背景情况:
- 冠状动脉CT血管造影 (CCTA) 的诊断图像质量受到患者心率 (HR) 的影响.
- 通常用于HR降低的β阻塞剂在儿科患者中有效性有限,潜在的低血压效应有限.
- 烯是一种α激动剂,可以通过诱导反射勃拉迪卡迪来提供另一种选择.
研究的目的:
- 评估烯在接受CCTA的儿科患者心率降低方面的疗效和安全性.
- 评估烯对CCTA研究中诊断图像质量的影响.
主要方法:
- 儿童患者的回顾性审查,这些患者接受了镇静性CCTA与费尼莱弗林的管理.
- 利弗林注射前后对心率变化的分析.
- 评估图像质量和报告的不良事件.
主要成果:
- 在25名儿科患者中,烯的使用导致心率平均从每分钟94.1跳减到每分钟73.8跳减.
- 观察到心率平均下降20次/分钟.
- 在所有患者中获得了诊断质量的图像,没有报告的不良反应.
结论:
- 烯是一种有效的降低心率的药物,在儿童患者在CCTA之前.
- 这种方法有助于在儿童中获得诊断质量的CCTA图像.
- 烯代表了一种安全有效的替代方案,用于心率管理儿科CCTA.
相关概念视频
Imaging Studies for Cardiovascular System V: CT
434
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
434
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.0K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.0K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.8K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K
Cardiac Catheterization I: Pre-Procedure Overview
1.8K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.8K
Regulation of Heart Rates
4.3K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
4.3K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
596
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
596


